This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Lumosa Therapeutics Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations in Stroke Treatment by Sheng-Wen Yeh
Introduction
Sheng-Wen Yeh is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical treatment, particularly in addressing acute ischemic stroke. His innovative approach has the potential to improve patient outcomes and enhance therapeutic strategies.
Latest Patents
Sheng-Wen Yeh holds a patent for a method of treating acute ischemic stroke. The patent, titled "Method for treating acute ischemic stroke," describes a process that involves administering one or more low doses of DC009, specifically in the range of about 0.01-0.075 mg/kg/dose. This low-dose administration has been found to be safe and effective for treating acute ischemic stroke in human subjects. He has 1 patent to his name.
Career Highlights
Sheng-Wen Yeh is associated with Lumosa Therapeutics Co., Ltd., where he continues to work on innovative solutions in the medical field. His research and development efforts focus on creating effective treatments for critical health conditions.
Collaborations
Some of his notable coworkers include David Chih-Kuang Chou and Ming Zhao. Their collaborative efforts contribute to the advancement of medical technologies and treatment methodologies.
Conclusion
Sheng-Wen Yeh's work in developing a method for treating acute ischemic stroke showcases his commitment to innovation in healthcare. His contributions are paving the way for improved treatment options for patients suffering from this serious condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile